Pier P. Leoncini
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study.
Journal: Hormone research in paediatrics
Published: February 19, 2024
Efficacy of a new combination of a microemulsion and oral supplementation for androgenetic alopecia: an interventional multicentric study.
Journal: Italian journal of dermatology and venereology
Published: January 24, 2022
MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors.
Journal: Oncology reports
Published: November 30, 2021
Alopecia areata treated with dimethyl fumarate: A case series.
Journal: Dermatologic therapy
Published: July 17, 2020
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
Journal: Diagnostic cytopathology
Published: February 24, 2020
Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review.
Journal: Current urology
Published: December 27, 2019
Correction to: HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy.
Journal: Cell death and differentiation
Published: November 01, 2019
HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy.
Journal: Cell death and differentiation
Published: January 28, 2019
Predictors of Hospitalization After Ureteroscopy Plus Elective Double-J Stent as an Outpatient Procedure.
Journal: Urologia internationalis
Published: June 20, 2018
Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.
Journal: British journal of haematology
Published: August 04, 2017
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.
Journal: Oncotarget
Published: April 04, 2016
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.
Journal: Clinical epigenetics
Published: December 21, 2014
Last Updated: 09/26/2026